Opens today: New Data Analytics Center is to give people better and safer medicines and medical devices

16 November 2020

Today, the Danish Medicines Agency officially opens its new Data Analytics Center (DAC), a center that is to translate information and data about medicines and medical devices into knowledge that will benefit the general public. Objective: Better and safer medicines and medical devices.

Today, the Danish Medicines Agency officially opens the new Data Analytics Center, DAC. It will take place with virtual, streamed opening speeches, including from Emer Cooke, Executive Director of the European Medicines Agency (EMA), and Claire Bury, Deputy Director-General of Health and Food Safety at the European Commission.

“As a citizen of Denmark and Europe you already find yourself in a favourable place when it comes to medicines, devices and treatment options. But there is still a wealth of data and information about medicines and devices that we are not using, which could potentially make a difference for people’s lives and health. Today, we are taking yet another important step to change this,” says Director General of the Danish Medicines Agency, Thomas Senderovitz.

The Danish Medicines Agency’s Data Analytics Center will use new technology and expertise within data analysis to obtain new knowledge about medicines and medical devices based on already available information from, for example, electronic health registers and on new data;  for instance wearables like smartwatches.

Regulation and monitoring of medicines in the 21st century

Prior to the opening, the Data Analytics Center has been expanding its competencies and capacity for about a year, and it is going to collaborate with drug regulatory authorities and research environments in Denmark, Europe and in the rest of the world.

“I have been so excited about today. In all modesty, it is also a fine day for not only the people in Denmark, but also for everyone in Europe and the rest of the world. Within a number of years, we expect to be able to analyse vast amounts of knowledge, so that our work of assessing, regulating and monitoring medicines and medical devices on behalf of the community may take place in an entirely new manner that will be shaping the 21st century and in a data ethics framework capable of setting a global standard that is rooted in Europe,” says Director General of the Danish Medicines Agency, Thomas Senderovitz.

Follow the official opening on YouTube here: https://youtu.be/tVz-ATm-4FM

Read more about the Danish Medicines Agency’s Data Analytics Center: lmst.dk/dac